Pàgina inicial > Resultats de la cerca: Tocchetti, C.G.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 2 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
7 p, 264.1 KB European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment / Lee, G.A. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Aktaa, S. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Baker, E. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Gale, C.P. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Yaseen, I.F. (Scientific Council of Cardiology. Iraqi Board for Medical Specializations) ; Gulati, G. (Oslo University Hospital (Oslo, Noruega)) ; Asteggiano, R. (LARC (Laboratorio Analisi e Ricerca Clinica)) ; Szmit, S. (Institute of Hematology and Transfusion Medicine) ; Cohen-Solal, A. (Cardiology Department. Hôpitaux de Paris. Hôpital Lariboisière 2 Rue Ambroise Paré) ; Abdin, A. (Department of Internal Medicine III. Cardiology. Angiology. Intensive Care Medicine. Saarland University Medical Center) ; Jurczak, W. (MSC National Research Institute of Oncology) ; Garrido, Pilar (Jefe Servicio Oncología Médica. Hospital Ramón y Cajal) ; Sverdlov, A.L. (Newcastle Centre of Excellence in Cardio-Oncology. Calvary Mater Newcastle. Hunter Medical Research Institute. John Hunter Hospital. University of Newcastle) ; Tocchetti, C.G. (Cardio-Oncology Unit. Department of Translational Medical Sciences (DISMET). Center for Basic and Clinical Immunology Research (CISI). Interdepartmental Center for Clinical and Translational Research (CIRCET). Interdepartmental Hypertension Research Center (CIRIAPA). Federico II University) ; Barac, A. (Cardio-oncology Program. MedStar Heart and Vascular Institute) ; Parrini, I. (Department of Cardiology. Mauriziano Hospital) ; Zamorano, P. (Hospital Universitario Ramón y Cajal (Madrid)) ; Iakobishvili, Z. (Faculty of Health Sciences. Ben Gurion University of the Negev) ; Pudil, R. (University Hospital Hradec Králové. Sokolská) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Kirby, A.M. (Royal Marsden NHS Trust. Institute of Cancer Research) ; Blaes, A.H. (Division of Hematology/Oncology/Transplantation. University of Minnesota) ; Farmakis, D. (University of Cyprus Medical School) ; Curigliano, Giuseppe (IRCCS. European Institute of Oncology) ; Stephens, R. (Patient Advocate) ; Lyon, A.R. (National Heart and Lung Institute. Imperial College London. Cardio-Oncology Service. Royal Brompton Hospital) ; Lopez-Fernandez, T. (Hospital Universitario La Paz. Instituto de Investigación IdiPAZ. Servicio de Cardiología)
Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. [...]
2023 - 10.1093/ehjqcco/qcac070
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9 Núm. 1 (january 2023) , p. 1-7  
Registre complet - Creative Commons
2.
18 p, 5.7 MB Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) / de Boer, Rudolf A.. (University Medical Center Groningen) ; Hulot, Jean-Sébastien (Université de Paris) ; Tocchetti, Carlo Gabriele (Federico II University) ; Aboumsallem, Joseph Pierre (University Medical Center Groningen) ; Ameri, Pietro (University of Genova. Department of Internal Medicine) ; Anker, Stefan D. (Charité - Universitätsmedizin Berlin) ; Bauersachs, Johann (Hannover Medical School) ; Bertero, Edoardo (University Clinic Würzburg) ; Coats, Andrew J. S. (San Raffaele Pisana Scientific Institute) ; Čelutkienė, Jelena (Vilnius University) ; Chioncel, O. (University of Medicine Carol Davila) ; Dodion, Pierre (Innate Pharma) ; Eschenhagen, Thomas (University Medical Center Hamburg. Institute of Experimental Pharmacology and Toxicology) ; Farmakis, D. (University of Cyprus Medical School) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Jäger, Dirk (Heidelberg University Hospital (Alemanya)) ; Jankowska, Ewa A. (Wroclaw Medical University. Department of Heart Diseases) ; Kitsis, Richard N. (Albert Einstein College of Medicine) ; Konety, Suma H. (University of Minnesota Medical School) ; Larkin, James (Royal Marsden NHS Foundation Trust) ; Lehmann, Lorenz (University of Heidelberg. Department of Cardiology) ; Lenihan, Daniel J. (Washington University in St. Louis) ; Maack, Christoph (University Clinic Würzburg) ; Moslehi, Javid J. (Vanderbilt University Medical Center) ; Müller, Oliver J. (University of Kiel. Department of Internal Medicine) ; Nowak-Sliwinska, Patrycja (University of Geneva. Institute of Pharmaceutical Sciences of Western Switzerland) ; Piepoli, Massimo Francesco (University of Parma) ; Ponikowski, Piotr (Wroclaw Medical University. Department of Heart Diseases) ; Pudil, Radek (University Hospital and Medical Faculty (Czech Republic)) ; Rainer, Peter P. (7 Medical University of Graz) ; Ruschitzka, Frank (University Hospital Zurich (Suïssa)) ; Sawyer, Douglas (Maine Medical Center) ; Seferovic, Petar M. (University of Belgrade) ; Suter, Thomas (Bern University) ; Thum, Thomas (Hannover Medical School) ; van der Meer, Peter (University Medical Center Groningen) ; Van Laake, Linda W. (Utrecht University) ; von Haehling, Stephan (University of Göttingen Medical Center. Department of Cardiology and Pneumology) ; Heymans, Stephane (Maastricht University. Department of Cardiology) ; Lyon, Alexander R. (Imperial College London. National Heart and Lung Institute) ; Backs, Johannes (Heidelberg University Hospital (Alemanya)) ; Universitat Autònoma de Barcelona. Departament de Medicina
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous commonalities in the biology underlying both pathologies. [...]
2020 - 10.1002/ejhf.2029
European Journal of Heart Failure, Vol. 22 (november 2020) , p. 2272-2289  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Tocchetti, Carlo Gabriele
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem